Literature DB >> 11465708

Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.

J H Ruth1, M V Volin, G K Haines, D C Woodruff, K J Katschke, J M Woods, C C Park, J C Morel, A E Koch.   

Abstract

OBJECTIVE: To examine the expression of the novel CX3C chemokine fractalkine (Fkn) and its receptor (CX3CR1) in rheumatoid arthritis (RA) and rat adjuvant-induced arthritis (AIA), a model of RA.
METHODS: Immunohistochemistry, flow cytometry, enzyme-linked immunosorbent assay (ELISA), reverse transcriptase-polymerase chain reaction (RT-PCR), and chemotaxis assays were used.
RESULTS: In rat AIA, synovial tissue (ST) macrophages, fibroblasts, endothelial cells, and dendritic cells were Fkn immunopositive, whereas lymphocytes did not significantly express Fkn. Significant staining for CX3CR1 was found in ST macrophages, fibroblasts, and dendritic cells, whereas only a small percentage of endothelial cells stained for CX3CR1 in rat AIA. We immunolocalized Fkn to RA ST macrophages, fibroblasts, endothelial cells, and dendritic cells. We also found intense ST macrophage and dendritic cell staining for CX3CR1 in RA ST. Flow cytometry analysis of RA synovial fluid (SF) and peripheral blood revealed a greater percentage of monocytes expressing Fkn and CX3CR1 compared with T cells. By ELISA, we found significantly elevated soluble Fkn (sFkn) levels in RA SF compared with SF from patients with osteoarthritis or other forms of arthritis. By RT-PCR, we found enhanced expression of Fkn and CX3CR1 mRNA on day 18 in rat AIA, a time of pronounced inflammation in the rat joint. Soluble Fkn-depleted RA SF showed significantly decreased chemotactic activity for monocytes compared with sham-depleted RA SF.
CONCLUSION: These results indicate that Fkn and its receptor are both expressed in RA and in rat AIA, and that sFkn is up-regulated in RA SF. Furthermore, our data suggest a new role for Fkn in monocyte chemotaxis in the inflamed RA joint.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465708     DOI: 10.1002/1529-0131(200107)44:7<1568::AID-ART280>3.0.CO;2-1

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  79 in total

1.  TLR5, a novel and unidentified inflammatory mediator in rheumatoid arthritis that correlates with disease activity score and joint TNF-α levels.

Authors:  Nathan D Chamberlain; Olga M Vila; Michael V Volin; Suncica Volkov; Richard M Pope; William Swedler; Arthur M Mandelin; Shiva Shahrara
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

2.  Decreased Th17 and antigen-specific humoral responses in CX₃ CR1-deficient mice in the collagen-induced arthritis model.

Authors:  Teresa K Tarrant; Peng Liu; Rishi R Rampersad; Denise Esserman; Lisa R Rothlein; Roman G Timoshchenko; Marcus W McGinnis; David J Fitzhugh; Dhavalkumar D Patel; Alan M Fong
Journal:  Arthritis Rheum       Date:  2012-05

Review 3.  Metalloproteinases, inflammation, and rheumatoid arthritis.

Authors:  F F Mohammed; D S Smookler; R Khokha
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

4.  Synovial inflammation in patients with osteonecrosis of the femoral head.

Authors:  Bradley J Rabquer; Giselle J Tan; Philip J Shaheen; G Kenneth Haines; Andrew G Urquhart; Alisa E Koch
Journal:  Clin Transl Sci       Date:  2009-08       Impact factor: 4.689

5.  Transcriptomic response of rat hippocampus and spleen cells to single and chronic administration of the peptide selank.

Authors:  T A Kolomin; M I Shadrina; Ya V Agniullin; S I Shram; P A Slominskii; S A Limborska; N F Myasoedov
Journal:  Dokl Biochem Biophys       Date:  2010 Jan-Feb       Impact factor: 0.788

6.  Expression and function of CXCL16 in a novel model of gout.

Authors:  Jeffrey H Ruth; Monica D Arendt; M Asif Amin; Salahuddin Ahmed; Hubert Marotte; Bradley J Rabquer; Charles Lesch; Solhee Lee; Alisa E Koch
Journal:  Arthritis Rheum       Date:  2010-08

7.  Pancreatic stellate cells and CX3CR1: occurrence in normal pancreas and acute and chronic pancreatitis and effect of their activation by a CX3CR1 agonist.

Authors:  Masahiko Uchida; Tetsuhide Ito; Taichi Nakamura; Masayuki Hijioka; Hisato Igarashi; Takamasa Oono; Masaki Kato; Kazuhiko Nakamura; Koichi Suzuki; Ryoichi Takayanagi; Robert T Jensen
Journal:  Pancreas       Date:  2014-07       Impact factor: 3.327

8.  Application of an electrochemiluminescence assay for quantification of E6011, an antifractalkine monoclonal antibody, to pharmacokinetic studies in monkeys and humans.

Authors:  Muneo Aoyama; Yuji Mano
Journal:  J Clin Lab Anal       Date:  2018-07-20       Impact factor: 2.352

Review 9.  Chemokines in joint disease: the key to inflammation?

Authors:  J J Haringman; J Ludikhuize; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-04-13       Impact factor: 19.103

Review 10.  The role of chemokines in leucocyte-stromal interactions in rheumatoid arthritis.

Authors:  Andrew Filer; Karim Raza; Mike Salmon; Christopher D Buckley
Journal:  Front Biosci       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.